Skip to content
Saturday 22 August 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE · FR
MorningWire

European business, markets and politics

FTSE 100
10,816.56
+0.64%
DAX
26,136.56
+0.59%
CAC 40
8,484.43
+0.37%
STOXX 50
6,462.22
+0.63%
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
More
GermanyFranceEU InstitutionsCompetitionPublic AffairsBankingTechnologyEnergy
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
  • DE
Monday 16 May 2022 6:30 am  |  Updated:  Friday 13 May 2022 3:42 pm

Sadiq Khan could be leading the way in deserting the foolish war on drugs

By: Eliot Wilson

Add as a preferred source on Google
London Mayor Celebrates Labour's Historic Council Wins In Westminster, Barnet and Wandsworth
Sadiq Khan said he will look at decriminalising cannabis during his visit to the United States. (Photo by Hollie Adams/Getty Images)

Those who like to think they take the long view of history will tell you that the “war on drugs” started in 1971, when Richard Nixon declared illegal narcotics to be public enemy number one. Yet its lineage extended far further back than that: in the US, Congress banned alcohol for nearly 15 years from 1920 to 1933. But the combative tone, the idea that we are locked in a struggle against drugs or the drug trade persists. It pervades the language we use, from “beating” addiction to “clamping down” on drug abuse.

Every so often, a political figure or pressure group will edge forward into the spotlight and suggest that there should be some greater nuance to our approach to drugs. These can be minor suggestions, such as non-custodial sentences for possession, or radical ideas, like wholesale legalisation.

There is always a backlash, because the media, following what’s assumed to be the public mood, prefers the chiaroscuro of “drugs are bad” to the sfumato of “well, actually” and a more creative and measured approach.

The mayor of London, Sadiq Khan, is the latest politician to step into this debate. Last week he was touring the United States as the capital’s global ambassador, and during his visit to Los Angeles he included a tour of a cannabis factory, or “cannabis dispensary and cultivation facility” in California’s language. Policy in the US is moving quickly: the non-medical use of cannabis is now legal in eighteen states, and decriminalised in a further thirteen. The direction of travel is clear, and it seems only a matter of time until cannabis is a legal and recreational substance across America.

Khan won re-election on a pledge to establish a London drugs commission, and has called for an “evidence-based approach” to legislation and control. Last week he used the opportunity of his visit to Los Angeles to announce his making good of that pledge. Indeed, Khan has asked Lord Falconer of Thoroton, Tony Blair’s lord chancellor and a shadow minister, to chair a review of the status of cannabis (which is a class B drug). The review will not extend to class A substances like cocaine and heroin.

It is always sensible to assay Khan’s public utterances for authenticity. One should note that neither City Hall nor the London Assembly has power over criminal justice, which is reserved to Parliament in England. The mayor, always alive to the chance of publicity, will hope to influence the debate. With due caution, it is fair to agree that a radical and firm proposal from the man with the biggest individual electoral mandate in the country would carry a degree of weight.

He is likely to have noted that regulating the sale and supply of cannabis in Los Angeles has created a new revenue stream for the city government. Here, after all, is a widely used commodity begging to be taxed like alcohol or tobacco. The legalisation has also cut cannabis-related arrests by 56 per cent, no small prize when police budgets and resources are stretched so thinly. The potential gains for a mayor are obvious to see.

Sadiq Khan is not home secretary, so he cannot directly influence public law on drugs, no matter what Charlie Falconer may conclude. The mayor is, however, chair of C40 Cities, a group of mayors of nearly 100 cities organised to tackle climate change. Might it be possible to assemble a similar coalition to address the issue of drugs and drug-related crime on an international urban basis?

Drug policy is an emotive issue. I tend towards liberalisation: it is the criminal context of drugs which has contributed hugely to the harm, and there is no rational basis for banning cannabis while alcohol and tobacco are legal. People should also generally be free to make informed choices for themselves. Whatever your view, it is obvious that the “war on drugs” is being lost, and lost comprehensively. Something has to change.

Khan is offering a possible way forward to this contentious policy area, and this should be cause for celebration. Not always an easy man to trust, the mayor has the opportunity to lead not just a national but an international debate, the chance to show courage and leadership on a problem which affects society from top to bottom. He can ask for the evidence he wants: will he be brave enough to follow through?

Read more

Cycle Pharmaceuticals Selects Forma Life Sciences to Establish U.S. Commercial Supply for FDA-Approved CAVHANZA™ (nilotinib) Orally Disintegrating Tablets

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • Opinion

Categories

  • Opinion

Trending Articles

  • House prices in wealthy London boroughs fall by up to £300,000

  • Ratcliffe’s Ineos saves Runcorn plant

  • Amazon says it buys books in bulk to ‘improve products’

  • Mike Ashley’s Frasers offers to pay personal shoppers in Harvey Nichols takeover

  • As it happened: FTSE 100 rallies after JD Sports drags on blue chips; oil jumps again

More from Morning Wire

  • Cycle Pharmaceuticals Selects Forma Life Sciences to Establish U.S. Commercial Supply for FDA-Approved CAVHANZA™ (nilotinib) Orally Disintegrating Tablets

    Business Wire
  • Compass Pathways Announces Second Quarter and First Half 2026 Financial Results and Business Highlights

    Business Wire
  • As it happened: FTSE 100 drops as oil prices rise after Trump makes Hormuz threat

    FTSE 100 Live
    Donald Trump speaking at a podium, microphone visible, discussing the Strait of Hormuz
  • Astrazeneca share price tumbles on $400bn megamerger talks

    Investing
    Astrazeneca headquarters with logo, reflecting commitment to reduce US medicine prices after Trump administration pressure
  • ‘Absurd’: Government seeks quantum tech chief – no experience necessary

    Tech
    Advanced quantum computer with intricate circuits and glowing interface, illustrating cutting-edge technology innovations
  • FTSE 100 Beazley profit plunges as war roils insurance market

    Insurance
    Beazley 2026 business forecast graph with financial data and growth trends displayed for February 24 analysis
  • As It Happened: Stocks dip as oil’s ‘slowing demand’ in focus; Iran threatens to extend war

    FTSE 100 Live
    People on a beach with cargo ships and a small boat in the Strait of Hormuz
  • On this day: Animal Farm is published

    Opinion
    Black and white image of pigs in wooden pens, facing each other across a narrow, muddy aisle on a farm.
MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • EU Institutions
  • Europe

Business

  • Markets
  • Business
  • Economy
  • Regulation
  • Competition
  • Public Affairs

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook